← Back to Search

Educational Tools for Cancer Genetic Testing (OPT-IN Trial)

N/A

Waitlist Available

Led By Huma Q Rana, MD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

OPT-IN Trial Summary

This trial will compare the effectiveness of video education vs. chatbot education for people without medical knowledge.

Who is the study for?

This trial is for adults over 18 with advanced stage (3 or 4) breast, ovarian, prostate cancer, or any stage of pancreatic cancer. Participants must not have had prior genetic testing for cancer and must be able to consent in English. Pregnant women and prisoners are excluded.Check my eligibility

What is being tested?

The study compares two methods of educating patients about genetic testing: one group will receive information through a chatbot, while the other will watch an educational video. The goal is to see which method is more effective before they get tested.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating in the study.

OPT-IN Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Meaningful cancer treatment changes

Satisfaction with pre-genetic test education

The measurement of genetic testing uptake

Secondary outcome measures

Cascade testing of family members

Communication of results with family members

Decisional regret

+2 more

OPT-IN Trial Design

2Treatment groups

Experimental Treatment

Group I: Video EducationExperimental Treatment1 Intervention

Participant is given a pamphlet introducing genetic testing Participant is given information utilized for clinical, standard of care testing. Participant will watch a brief educational video that is approximately 8 minutes in length about the genetic testing process and what to expect prior to genetic testing. After the video education, participant is asked if they would like to proceed with genetic testing. Participant is asked to complete an electronic family history tool

Group II: ChatbotExperimental Treatment1 Intervention

Participant is given a pamphlet introducing genetic testing Participant is given information utilized for clinical, standard of care testing. Will receive genetic information with a virtual interactive Chatbot prior to genetic testing. After the Chatbot education, participant is asked if they would like to proceed with genetic testing. Participant is asked to complete an electronic family history tool

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,647 Total Patients Enrolled

141 Trials studying Breast Cancer

22,316 Patients Enrolled for Breast Cancer

Huma Q Rana, MDPrincipal InvestigatorDana-Farber Cancer Institute

1 Previous Clinical Trials

662 Total Patients Enrolled

Media Library

Chatbot Clinical Trial Eligibility Overview. Trial Name: NCT04066361 — N/A

Breast Cancer Research Study Groups: Video Education, Chatbot

Breast Cancer Clinical Trial 2023: Chatbot Highlights & Side Effects. Trial Name: NCT04066361 — N/A

Chatbot 2023 Treatment Timeline for Medical Study. Trial Name: NCT04066361 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any enrollments slots left for this research program?

"That is correct. The information available on clinicaltrials.gov indicates that this study is actively looking for patients. This trial was first posted on December 19th, 2019 and was last updated on April 14th, 2020. The study is hoping to enroll 1200 participants at 1 location."

Answered by AI

What primary objectives does this research study hope to establish?

"The purpose of this research, which will be accessed through post-counseling/video pre-result disclosure and take place over a 3-week period, is to study The uptake of genetic testing. Additionally, this trial will measure Communication of results with family members (which is defined as For those participants who have tested positive for a mutation, 5 items will be asked pertaining to disclosure of genetic testing results to relatives that are derived from previous literature.), Decisional regret (which is defined as 5 items will be asked pertaining to reflecting on the decision of the participant about getting genetic testing after learning about their result.), and Intent to disclose genetic"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

OPTimizing Treatment Focused Genetic Testing IN Cancer

Huma Rana, MD 2019. "OPTimizing Treatment Focused Genetic Testing IN Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04066361.